Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 11/2006

01-09-2006 | Case Report

Microscopic polyangiitis complicated by cerebral haemorrhage

Authors: S. Han, H. U. Rehman, P. S. Jayaratne, J. E. Carty

Published in: Rheumatology International | Issue 11/2006

Login to get access

Excerpt

Microscopic polyangiitis (MPA) is a necrotizing systemic vasculitis with few or no immune deposits affecting small vessels. Although MPA was initially included in the category of polyarteritis nodosa (PAN), this is no longer acceptable and is now considered a distinct entity [1]. Clinical manifestations are extremely varied but nephritis, pulmonary haemorrhage, purpura, peripheral neuropathy, abdominal pain, and arthralgias are common signs and symptoms. We present a case of MPA complicated by fatal cerebral haemorrhage, which is a rare manifestation of this form of systemic vasculitis. …
Literature
1.
Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. The proposal of an international consensus conference. Arthritis Rheum 37:187–92PubMedCrossRef
2.
Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M et al. (1999) Microscopic polyangiitis. Clinical and laboratory findings in eighty five patients. Arthritis Rheum 42:421–30PubMedCrossRef
3.
Jennette JC, Thomas B, Falk RJ (2001) Microscopic polyangiitis. Sem Diag Pathol 18:3–13
4.
Hearne CB, Zawada ET Jr (1982) Survival after intracerebral hemorrhage in Wegener’s granulomatosis. West J Med 137:431–4PubMed
5.
Liou HH, Liu HM, Chiang IP, Yeh TS, Chen RC (1997) Churg-Strauss syndrome presented as multiple intracerebral hemorrhage. Lupus 6:279–82PubMedCrossRef
6.
Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. QJM 56:467–83PubMed
7.
Fenton JE, O’Sullivan TJ (1994) The otological manifestations of Wegener’s granulomatosis. J Laryng Otol 108(2):144–6
8.
Lhote F, Cohen P, Guillevin L (1998) Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 7:238–258PubMedCrossRef
9.
Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107PubMedCrossRef
Metadata
Title
Microscopic polyangiitis complicated by cerebral haemorrhage
Authors
S. Han
H. U. Rehman
P. S. Jayaratne
J. E. Carty
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0136-1

Other articles of this Issue 11/2006

Rheumatology International 11/2006 Go to the issue

Original Article

The association between total antioxidant status and oxidative stress in Behçet’s disease

Original Article

Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis

Original Article

Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment

Review

The treatment of the rheumatological manifestations of the inflammatory bowel diseases

Original Article

Enhancement of anti-inflammatory tendency by SB203580, p38α specific inhibitor, in human fibroblast-like synoviocyte cell line, MH7A

Original Article

Enhanced production of MMP-1, MMP-3, MMP-13, and RANTES by interaction of chondrocytes with autologous T cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits